iugr long question paediatric

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Now I have sufficient material from the textbooks. Let me compile a comprehensive long-question answer on IUGR from the paediatric perspective.

Intrauterine Growth Restriction (IUGR) - Long Question (Paediatrics)


Definition

Intrauterine Growth Restriction (IUGR) refers to a condition in which the fetus fails to achieve its genetically predetermined growth potential. It is most commonly defined as a birth weight below the 10th percentile for gestational age (some definitions use the 3rd or 5th percentile, or >2 SD below the mean). It should be distinguished from "Small for Gestational Age (SGA)," which is purely a statistical birth weight descriptor; IUGR specifically implies a pathological failure of growth as detected by serial ultrasonography.
  • Medical Physiology, p. 1678; Robbins & Kumar Basic Pathology, p. 136

Classification

IUGR is classified into three types based on the timing and nature of the causative insult:

1. Symmetrical IUGR (20-30% of cases)

  • All parameters affected uniformly: weight, length, head circumference all <10th percentile
  • Results from a long-standing insult in early gestation (4-20 weeks) during the hyperplastic phase (when cell numbers increase)
  • Fewer total cells in the fetus ("decreased cell number")
  • Causes: Chromosomal disorders (trisomies), congenital infections (TORCH: Rubella, CMV, Toxoplasmosis), congenital malformations, maternal alcohol/drug/tobacco use, severe maternal malnutrition
  • ~25% of severely affected early-onset cases have aneuploidy

2. Asymmetrical IUGR (70-80% of cases)

  • Weight is most affected; length less so; head circumference is relatively spared ("brain-sparing effect")
  • Results from an insult in later gestation (after 28 weeks) during the hypertrophic phase (cell enlargement and fat/muscle accretion)
  • Due to redistribution of fetal blood to the brain, heart, and adrenals at the expense of the liver, adipose tissue, and abdominal organs
  • Causes: Uteroplacental insufficiency (most common), pre-eclampsia, chronic maternal hypertension, renal disease, severe diabetes with vascular disease, multiple gestation

3. Intermediate / Combined IUGR (5-10% of cases)

  • Occurs during the middle phase of fetal growth (20-28 weeks)
  • Caused by conditions like chronic hypertension or lupus nephritis starting early in the second trimester
  • Shows symmetric growth pattern but without significant brain-sparing
Medical Physiology, p. 1678-1679

Etiology / Causes

A. Fetal Causes

  • Chromosomal abnormalities: Trisomy 13, 18, 21 (birth weights lowest in T13/T18)
  • Congenital structural anomalies (22.3% of anomalous infants have IUGR)
  • Congenital infections: TORCH (Rubella, CMV most established); Varicella, Toxoplasmosis, HIV, Malaria, Zika
  • Metabolic disorders

B. Maternal Causes (most common category)

  • Vascular disease: Pre-eclampsia, chronic hypertension
  • Hypercoagulable states (acquired or inherited thrombophilia)
  • Renal disease, Systemic Lupus Erythematosus
  • Severe diabetes mellitus with vascular insufficiency
  • Malnutrition (particularly third-trimester caloric restriction <1500 kcal/day)
  • Teratogenic drugs: Phenytoin, warfarin, methotrexate, alcohol, narcotics
  • Heavy smoking: Associated with small placentas and low birth weight
  • High altitude (reduced oxygen availability)
  • Multiple gestation

C. Placental Causes

  • Placenta previa (low implantation)
  • Placental abruption (retroplacental haematoma)
  • Placental infarction
  • Umbilical cord anomalies (single umbilical artery)
  • Twin-twin transfusion syndrome (monochorionic twins)
  • Histologic chorioamnionitis
Robbins Basic Pathology, p. 136-137; Creasy & Resnik MFM, p. 1037-1038

Pathophysiology

The fundamental pathway in most IUGR (especially asymmetric) is uteroplacental insufficiency leading to chronic fetal hypoxia and nutritional deprivation. In response:
  1. Fetal haemodynamic redistribution: Doppler studies show increased resistance in the umbilical artery and decreased resistance in the middle cerebral artery ("brain-sparing"). In severe cases, absent or reversed end-diastolic flow in the umbilical artery indicates critical compromise.
  2. Hormonal changes: Reduced IGF-1 (major intrauterine growth factor under nutritional control), reduced insulin levels; conversely, cortisol may be elevated.
  3. Metabolic adaptation: Decreased fat, glycogen, and protein deposition. The liver (a major glycogen store) is disproportionately small, explaining hypoglycaemia after birth.
  4. Haematopoietic response: Chronic hypoxia stimulates erythropoietin → polycythaemia.

Clinical Features / Recognition at Birth

Physical Appearance

  • Low birth weight for gestational age
  • Loose, dry, wrinkled skin with decreased subcutaneous fat (depleted fat stores)
  • Thin, wasted limbs; prominent ribs
  • Relatively large-appearing head (in asymmetric IUGR)
  • Reduced abdominal circumference (small liver)
  • Alert, wide-eyed appearance ("old man" facies)
  • Meconium-stained skin, nails, and cord (chronic hypoxia causes meconium passage in utero)

Ponderal Index (PI)

  • PI = Birth weight (g) × 100 / Crown-heel length (cm)³
  • In asymmetric IUGR: PI is low (wasted)
  • In symmetric IUGR: PI may be normal

Neonatal Complications

This is a high-yield list for exams:
ComplicationMechanism
Perinatal asphyxiaUteroplacental insufficiency; reduced reserve during labour
Meconium aspiration syndromeIn utero hypoxia → vagal stimulation → meconium passage
HypoglycaemiaDepleted glycogen stores + hyperinsulinism (relative)
HypothermiaDepleted subcutaneous fat; increased surface area:body mass ratio
Polycythaemia / hyperviscosityChronic hypoxia → ↑ erythropoietin → ↑ RBC production
HypocalcaemiaPoor calcium stores, asphyxia-related
Necrotising enterocolitis (NEC)Hypoxic redistribution away from gut; ischaemic injury
Persistent Pulmonary Hypertension (PPHN)Chronic intrauterine hypoxia → pulmonary vascular remodelling
Pulmonary haemorrhagePolycythaemia, PPHN
ThrombocytopeniaBone marrow suppression from hypoxia
ImmunodeficiencyThymic atrophy, reduced lymphocyte function
JaundicePolycythaemia → increased bilirubin load
Medical Physiology (Box 57-1, p. 1678)

Antenatal Diagnosis

Ultrasonography (key tool)

  • Biometric parameters: Biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC), femur length (FL) - plotted serially on growth charts
  • AC is the most sensitive single parameter (reflects liver size and fat stores)
  • HC/AC ratio: Elevated in asymmetric IUGR (head spared relative to abdomen)
  • Estimated fetal weight (EFW) <10th percentile for gestational age
  • Serial ultrasounds every 2-4 weeks to assess growth velocity

Doppler Studies

  • Umbilical artery: Increased systolic/diastolic ratio, absent end-diastolic flow (AEDF), or reversed end-diastolic flow (REDF) - each indicates progressively worsening placental resistance
  • Middle cerebral artery (MCA): Decreased resistance (compensatory vasodilation) - "brain sparing"
  • Cerebroplacental ratio (CPR): MCA PI / UA PI - reduced CPR is an adverse sign
  • Ductus venosus / umbilical venous pulsations: Absent or reversed 'a' wave in DV indicates imminent cardiac decompensation

Biophysical Profile (BPP)

  • Assesses fetal breathing movements, body movements, tone, amniotic fluid volume, NST
  • Score ≤4/10 is an indication for delivery

Other Investigations

  • Chromosomal analysis (karyotype ± microarray) when structural anomaly or early-onset severe IUGR
  • TORCH serology (maternal and sometimes fetal blood)
  • Maternal blood pressure, urine protein, renal function, antiphospholipid antibodies, CBC

Management

Antenatal

  1. Identify and treat underlying cause (control hypertension, manage diabetes, stop smoking/alcohol)
  2. Serial fetal surveillance: Growth ultrasound every 2-4 weeks; Doppler weekly or more frequently if abnormal
  3. Corticosteroids (Betamethasone 12 mg IM × 2 doses 24h apart): if delivery anticipated before 34 weeks - accelerates lung maturity
  4. Aspirin (low-dose, 150 mg nocte) started before 16 weeks - reduces placental dysfunction in high-risk women
  5. Timing of delivery: Balance fetal compromise against prematurity:
    • Absent/reversed end-diastolic flow: consider delivery at 34 weeks
    • Abnormal ductus venosus: deliver regardless of gestation
    • Continuous CTG abnormality: emergency delivery

Neonatal Management (Paediatrics focus)

At delivery:
  • Anticipate birth asphyxia; have full resuscitation team available
  • Clamp cord early only if baby compromised (delayed cord clamping preferred otherwise)
Immediate postnatal care:
  1. Prevent hypothermia: Warm environment, pre-warmed towels, incubator for preterm IUGR babies
  2. Blood glucose monitoring: Start within 30 minutes of birth; feed early (within 1 hour)
    • Target glucose >2.6 mmol/L (>47 mg/dL); IV dextrose if hypoglycaemia persists
  3. Manage polycythaemia: If symptomatic (plethora, respiratory distress, jitteriness, convulsions) with haematocrit >65%: partial exchange transfusion with normal saline
  4. Calcium supplementation if hypocalcaemic
  5. Watch for NEC: Avoid aggressive enteral feeds in asphyxiated IUGR neonates; start minimal enteral nutrition and build up slowly
  6. Respiratory support: If meconium aspiration or PPHN - oxygen, CPAP, mechanical ventilation, inhaled NO for PPHN

Long-term Consequences

IUGR has significant long-term effects that extend well into adulthood:
  1. Neurodevelopmental: Cerebral dysfunction, learning disabilities, attention deficit, sensory impairment (visual and hearing), lower IQ - particularly in symmetric IUGR
  2. Growth: Approximately 10-15% of IUGR children fail to show "catch-up growth" and remain short; growth hormone therapy may be indicated in SGA children with persistent short stature after age 4 years
  3. Barker Hypothesis / Developmental Origins of Health and Disease (DOHaD): Fetal undernutrition programs permanent metabolic changes:
    • Type 2 diabetes mellitus
    • Insulin resistance / metabolic syndrome
    • Hypertension
    • Cardiovascular disease (coronary artery disease)
    • Chronic kidney disease (reduced nephron number from impaired nephrogenesis)
  4. Reproductive: Girls who were IUGR have increased risks in their own pregnancies
Robbins Basic Pathology, p. 137; Brenner & Rector's The Kidney, p. 1723

Summary Table: Symmetric vs Asymmetric IUGR

FeatureSymmetric IUGRAsymmetric IUGR
Proportion20-30%70-80%
Timing of insultEarly (4-20 wk)Late (after 28 wk)
Growth phaseHyperplasticHypertrophic
PathologyFewer cellsSmaller cells, depleted glycogen/fat
Head circumferenceReducedRelatively spared (brain-sparing)
HC/AC ratioNormalElevated
Ponderal IndexNormalReduced (wasted)
Brain-sparingAbsentPresent
Common causesTORCH, chromosomal, drugsUteroplacental insufficiency, PIH
PrognosisWorse (fewer neurons)Better if caught early

Important Exam Points (High-Yield)

  • IUGR definition: birth weight <10th percentile for gestational age
  • Most common type: Asymmetric (70-80%), due to uteroplacental insufficiency
  • Most common neonatal complication: Hypoglycaemia (depleted glycogen stores)
  • Brain-sparing = relatively preserved head circumference in asymmetric IUGR
  • "TORCH" infections = symmetric IUGR
  • Absent/reversed umbilical artery end-diastolic flow = severe fetal compromise
  • Long-term: Barker hypothesis - increased risk of adult-onset T2DM, hypertension, CAD
  • IUGR children not showing catch-up by age 4 → consider recombinant GH therapy

Sources: Medical Physiology (Boron & Boulpaep), p. 1678-1679 | Robbins & Kumar Basic Pathology, p. 136-137 | Creasy & Resnik's Maternal-Fetal Medicine, p. 1037-1038
This is a shared conversation. Sign in to Orris to start your own chat.